enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Does Medicare cover ketamine infusions for mental health ...

   www.aol.com/does-medicare-cover-ketamine...

   A doctor may prescribe Spravato for treatment-resistant depression. A person needs to consult with their healthcare team and insurer before undergoing ketamine infusion for mental health treatment.

3. Mindbloom - Wikipedia

   en.wikipedia.org/wiki/Mindbloom

   Mindbloom is an American telemedicine company that treats anxiety and depression via ketamine-assisted therapy. It was founded in 2018 by Dylan Beynon. It was founded in 2018 by Dylan Beynon. The company has contributed to studies researching the effectiveness of ketamine as a treatment for mental health related issues.

4. Ketamine-assisted psychotherapy - Wikipedia

   en.wikipedia.org/wiki/Ketamine-assisted...

   Ketamine-assisted psychotherapy (KAP) is the use of prescribed doses of ketamine as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety, obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. [1]

5. FDA approves standalone use of J&J’s ketamine-derived ... - AOL

   www.aol.com/fda-approves-standalone-j-j...

   The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the ...

6. Psychedelic therapy - Wikipedia

   en.wikipedia.org/wiki/Psychedelic_therapy

   Evidence is growing for the use of atypical psychedelics such as ketamine for treating depression in terminally ill patients, with repeated IV administration having the most therapeutic effect. [64] These studies did not have any patients experience any serious adverse effects; however, ketamine-induced ulcerative cystitis is a concern for ...

7. FDA approves Johnson & Johnson’s ketamine-derived ... - AOL

   www.aol.com/finance/fda-approves-johnson-johnson...

   "Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants or cannot tolerate them,” Bill Martin, neuroscience leader with the ...